气管切开产品市场机会、成长动力、产业趋势分析和 2025 - 2034 年预测

2024 年全球气管切开产品市场价值为 2.17 亿美元，预计将大幅成长，预计 2025 年至 2034 年期间的复合年增长率为 5.1%。这种扩张源于多种因素，包括气管切开技术的进步、儿科呼吸道疾病盛行率的增加、呼吸照护意识的提高以及人口老化的增长。由于重症监护入院人数增加和慢性呼吸系统疾病负担加重，对呼吸照护解决方案的需求不断增加，进一步凸显了市场的潜力。此外，气管切开产品的持续创新，例如抗菌涂层、无袖口设计和灵活的客製化管，正在满足患者对安全性、舒适性和效率的关键需求。全球各地的医疗机构越来越多地采用这些尖端技术，凸显了市场的发展前景。

市场按产品类型分类，包括气管切开管、通气配件、清洁和护理套件以及其他相关产品。气管切开管占据了市场主导地位，2024 年市场价值为 1.123 亿美元。这些管子对于气道状况的管理仍然至关重要，因为它们有助于有效通气，同时最大限度地减少併发症。气管切开管的技术进步，例如抗菌材料和创新设计，正在改善患者的治疗效果并提高长期呼吸护理的整体安全性。此外，创伤、中风和严重感染引起的重症监护病例不断增加，也增加了医院和家庭护理环境中对气管切开管的需求。

市场也按技术细分，经皮扩张气管切开术和手术气管切开术是两种主要方法。经皮扩张气管切开术在 2024 年的收入为 1.312 亿美元，由于其微创性质而成为首选技术。此方法只需一个小切口并使用扩张器来扩大气管，从而减少组织损伤、加快恢復时间并降低併发症的风险。重症监护环境中对这项技术的日益青睐反映了其有效性和对微创手术的日益增长的需求。

美国气管切开产品市场在 2024 年创造了 8,050 万美元的产值，预计在 2025 年至 2034 年期间的复合年增长率为 4.6%。美国在医疗技术创新方面处于领先地位，特别是在开发先进的气管切开解决方案方面，例如抗菌管、无袖口管和一次性管。这些进步提高了病患的安全性和舒适度，推动了医院和居家照护环境中的采用。此外，长期呼吸照护的优惠报销政策确保了高品质气管切开产品的可近性，进一步推动了市场成长。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 呼吸系统疾病发生率不断上升
    • 新兴市场医疗支出不断成长
    • 气管切开产品的技术进步
    • 外科手术增多
  • 产业陷阱与挑战
    • 先进产品成本高
    • 併发症风险
• 成长潜力分析
• 监管格局
• 技术格局
• 报销场景
• 波特的分析
• PESTEL 分析
• 差距分析
• 价值链分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：依产品类型，2021 年至 2034 年

• 主要趋势
• 气管切开管
  • 带套囊的气管切开插管
  • 无套囊气管切开插管
  • 有孔气管切开管
  • 无孔气管切开管
• 通风配件
• 清洁及护理套件
• 其他产品类型

第六章：市场估计与预测：按技术，2021 年至 2034 年

• 主要趋势
• 经皮扩张气管切开术
• 外科气管切开术

第 7 章：市场估计与预测：按病患类型，2021 — 2034 年

• 主要趋势
• 成人
• 儿科

第 8 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 专科诊所
• 门诊手术中心
• 其他最终用户

第九章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• Andreas FAHL
• ANGIPLAST
• Atos
• Boston Medical
• ConvaTec
• COOK MEDICAL
• Fisher & Paykel
• Fuji Systems
• MEDIS MEDICAL
• Medtronic
• Pulmodyne
• Smiths Group
• Teleflex
• TROGE
• wellead

The Global Tracheostomy Products Market, valued at USD 217 million in 2024, is poised for significant growth with a projected CAGR of 5.1% between 2025 and 2034. This expansion stems from various factors, including advancements in tracheostomy technology, the increasing prevalence of pediatric airway disorders, rising awareness of respiratory care, and the growing aging population. The escalating demand for respiratory care solutions, driven by an increase in critical care admissions and the rising burden of chronic respiratory conditions, further underscores the market's potential. Moreover, continuous innovations in tracheostomy products, such as antimicrobial coatings, cuffless designs, and flexible customized tubes, are addressing key patient needs for safety, comfort, and efficiency. The growing adoption of these cutting-edge technologies by healthcare facilities worldwide highlights the market's promising trajectory.

The market is categorized by product type, encompassing tracheostomy tubes, ventilation accessories, clean and care kits, and other related products. Tracheostomy tubes dominated the market, generating USD 112.3 million in 2024. These tubes remain integral to the management of airway conditions, as they facilitate effective ventilation while minimizing complications. Technological advancements in tracheostomy tubes, such as antimicrobial materials and innovative designs, are enhancing patient outcomes and improving the overall safety of long-term respiratory care. Additionally, the rising number of critical care cases caused by trauma, strokes, and severe infections has amplified the need for tracheostomy tubes in both hospital and home care settings.

The market is also segmented by technique, with percutaneous dilatational tracheostomy and surgical tracheostomy as the two primary methods. Percutaneous dilatational tracheostomy accounted for USD 131.2 million in 2024, emerging as the preferred technique due to its minimally invasive nature. This method involves a small incision and the use of a dilator to enlarge the trachea, which results in less tissue damage, faster recovery times, and a lower risk of complications. The growing preference for this technique in critical care settings reflects its effectiveness and the increasing demand for minimally invasive procedures.

The U.S. tracheostomy products market generated USD 80.5 million in 2024 and is expected to grow at a CAGR of 4.6% between 2025 and 2034. The United States leads in medical technology innovation, particularly in developing advanced tracheostomy solutions such as antimicrobial, cuffless, and disposable tubes. These advancements enhance patient safety and comfort, driving adoption in hospital and home care environments. Additionally, favorable reimbursement policies for long-term respiratory care ensure accessibility to high-quality tracheostomy products, further fueling market growth.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of respiratory disorders
    • 3.2.1.2 Growing healthcare expenditure in emerging markets
    • 3.2.1.3 Technological advancements in tracheostomy products
    • 3.2.1.4 Rise in surgical procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with advanced products
    • 3.2.2.2 Risk of complications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Gap analysis
• 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 — 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Tracheostomy tubes
  • 5.2.1 Cuffed tracheostomy tubes
  • 5.2.2 Uncuffed tracheostomy tubes
  • 5.2.3 Fenestrated tracheostomy tubes
  • 5.2.4 Non-fenestrated tracheostomy tubes
• 5.3 Ventilation accessories
• 5.4 Clean & care kits
• 5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Technique, 2021 — 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Percutaneous dilatational tracheostomy
• 6.3 Surgical tracheostomy

Chapter 7 Market Estimates and Forecast, By Patient Type, 2021 — 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Adult
• 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Specialty clinics
• 8.4 Ambulatory surgical centers
• 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Andreas FAHL
• 10.2 ANGIPLAST
• 10.3 Atos
• 10.4 Boston Medical
• 10.5 ConvaTec
• 10.6 COOK MEDICAL
• 10.7 Fisher & Paykel
• 10.8 Fuji Systems
• 10.9 MEDIS MEDICAL
• 10.10 Medtronic
• 10.11 Pulmodyne
• 10.12 Smiths Group
• 10.13 Teleflex
• 10.14 TROGE
• 10.15 wellead